Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Naviel Bio Pharma Science Private Limited, is an unlisted private company incorporated on 29 June, 2015. It is classified as a private limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 20.00 lac and the total paid-up capital is INR 5.59 lac.
The current status of Naviel Bio Pharma Science Private Limited is - Active.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Gayatri Ganapati Gurudatta | 02178855 | 10 years |
Additional Director | Mahadeshana Muniswamy | 02342100 | 10 years |
Additional Director | Venkateshappa Muniswamappa | 02342109 | 10 years |
Additional Director | Manjunath Muniswamappa | 02425631 | 10 years |
Director | Rachappaji Siddasetty | 03392581 | 10 years |
Director | Havanur Anilkumar | 06773649 | 10 years |
Director | Ashok Kumar Hegde | 06894537 | 10 years |
Director | Doraiswamy Rajeevalochana | 07209869 | 10 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
NAVIEL PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
10.0 L | 2 | Karnataka |
AMOGHA PHARMA & CLINICAL RESEARCH PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
ESTIMA PHARMACEUTICALS PRIVATE LIMITED |
Active
|
10.0 L | 1 | Karnataka |
ESTIMA PHARMA SOLUTIONS LLP |
Active
|
5.0 L | 1 | Karnataka |
MANNA STUDIO PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Karnataka |
TRIVENI GLOBAL VENTURES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
AMIT ROYALINFRA SPACES PRIVATE LIMITED |
Strike Off
|
1.0 L | 3 | Maharashtra |
MAHAA INFRA PROJECTS PRIVATE LIMITED |
Strike Off
|
1.0 L | 3 | Karnataka |
MIRACLE TOURS AND TRAVELS PRIVATE LIMITED |
Strike Off
|
1.0 L | 3 | Karnataka |
TANVIRAJ BIOPHARMA CARE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED |
Active
|
5.4 Cr | 1 | Karnataka |
ORBION PHARMACEUTICALS PRIVATE LIMITED |
Active
|
175.0 Cr | 1 | Tamil Nadu |
EKARAKSHA HEALTH CARE SERVICES INDIA LIMITED |
Active
|
10.0 L | 1 | Karnataka |
Read more
The incorporation date of NAVIEL BIO PHARMA SCIENCE PRIVATE LIMITED is 29 June, 2015
The authorized share capital of NAVIEL BIO PHARMA SCIENCE PRIVATE LIMITED is INR ₹ 20.0 L.
The paid-up capital of NAVIEL BIO PHARMA SCIENCE PRIVATE LIMITED is INR ₹ 5.6 L.
The registered address of NAVIEL BIO PHARMA SCIENCE PRIVATE LIMITED is NO.120, DOREMANE, 5TH CROSS 1ST BLOCK, NAGASANDRA POST, HMT LAYOUT BANGALORE Bangalore Karnataka - 560073
The CIN number of NAVIEL BIO PHARMA SCIENCE PRIVATE LIMITED is U85110KA2015PTC081229.